HEDS is part of the School of Health and Related Research (ScHARR) at the University of Sheffield. We undertake research, teaching, training and consultancy on all aspects of health related decision science, with a particular emphasis on health economics, HTA and evidence synthesis.

Monday, 6 February 2012

Recent CUAs

Twice each month the CEA Registry Blog lists recently published cost utility studies and associated papers.  17 papers were listed this time. Here's a couple in our areas of research interest:

Cheng TF, Wang JD, Uen WC. Cost-utility analysis of adjuvant goserelin (Zoladex) and adjuvant chemotherapy in premenopausal women with breast cancer. BMC Cancer. 2012 Jan 21;12(1):33. [Epub ahead of print] PubMed PMID: 22264299.

van Rosmalen J, de Kok I, van Ballegooijen M. Cost-effectiveness of cervical cancer screening: cytology versus human papillomavirus DNA testing. BJOG. 2012 Jan 18. [Epub ahead of print] PubMed PMID: 22251259.